Cargando…
Assessment timing and choice of outcome measure in determining treatment response in chronic inflammatory demyelinating polyneuropathy: A post hoc analysis of the PRISM trial
INTRODUCTION/AIMS: Treatment response and its timing are variable in chronic inflammatory demyelinating polyneuropathy (CIDP). In this study we assessed the variability using multiple outcome measures. METHODS: We performed a post hoc analysis of the PRISM trial, a 24‐week prospective, multicenter,...
Autores principales: | Rajabally, Yusuf A., Ouaja, Rabye, Kasiborski, Fabrice, Pujol, Sonia, Nobile‐Orazio, Eduardo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9828128/ https://www.ncbi.nlm.nih.gov/pubmed/36057106 http://dx.doi.org/10.1002/mus.27713 |
Ejemplares similares
-
An international multicenter efficacy and safety study of IqYmune in initial and maintenance treatment of patients with chronic inflammatory demyelinating polyradiculoneuropathy: PRISM study
por: Nobile‐Orazio, Eduardo, et al.
Publicado: (2020) -
Tailoring of therapy for chronic inflammatory demyelinating polyneuropathy
por: Rajabally, Yusuf A.
Publicado: (2015) -
Underdiagnosis and diagnostic delay in chronic inflammatory demyelinating polyneuropathy
por: Chaudhary, Umair J., et al.
Publicado: (2020) -
Evolving Immunologic Perspectives in Chronic Inflammatory Demyelinating Polyneuropathy
por: Rajabally, Yusuf A, et al.
Publicado: (2020) -
Novel Therapeutic Avenues for Chronic Inflammatory Demyelinating Polyneuropathy: The Difficulties of Disease Diversity
por: Rajabally, Yusuf A.
Publicado: (2016)